Divergence Neuro

Canada
Toronto, Ontario, Canada, M5G 0A8

Company profile

Divergence Neuro company profile

Divergence is a mobile, cloud-based, AI-driven mental health technology platform that connects therapists and patients through smart relational technologies to achieve better outcomes in mental health care. Our platform provides a user-friendly, portable, and insightful service to enable mental health care providers to easily design, drive, and measure the outcome of mental health care with the help of advanced EEG analytics and Machine Learning predictive biomarker technologies. We provide the platform as a service for mental health care providers servicing those who are afflicted with addiction, depression, PTSD, anxiety, and ASD. Divergence also works with pharmaceutic technology companies to help validate the effectiveness of their compounds and treatments with neuroscience, ML and AI. In particular, we help companies that work with novel psychedelic therapy to validate the effects of their drugs and therapies by building biomarker model with EEG data in our research platform.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2020-10-03

Headquarters

Postal code
M5G 0A8
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Pre Seed / 2020-10-03
Last equity funding
Pre Seed
Founders
1
Articles
5

Founders and investors

Founders

Alex Ni